Skip to main content
Top
Published in: Autoimmunity Highlights 2/2014

01-09-2014 | Review Article

Efficiency of a solid-phase chemiluminescence immunoassay for detection of antinuclear and cytoplasmic autoantibodies compared with gold standard immunoprecipitation

Authors: Carmen Gelpí, Elena Pérez, Cristina Roldan

Published in: Autoimmunity Highlights | Issue 2/2014

Login to get access

Abstract

Purpose

The aim of this study was to compare the degree of agreement of a novel Zenit RA chemiluminescent immunoassay (CLIA) from A. Menarini Diagnostics (Florence, Italy) and the gold standard immunoprecipitation assay to screen for the presence of specific anti-U1snRNP, anti-Sm, anti-Ro/SS-A, anti-La/SS-B, anti-Jo-1(histRNA-Synthetase) and anti-Scl-70(Topo I) antibodies.

Materials and methods

We studied 114 sera, 98 from patients with well-defined autoimmune connective tissue diseases and 16 from blood donor volunteers. All samples were fully characterized using the new chemiluminescent immunoassay and immunoprecipitation. In addition, all the samples were analyzed by indirect immunofluorescence (IIF) and anti-Scl-70(Topo I) antibodies were analyzed by immunoblot (IB) assay. Discrepant samples were analyzed using a commercial dot blot technique (Recomline from Mikrogen). The simple Kappa coefficient was used to measure the level of agreement between the results of Zenit RA CLIA and the gold standard.

Results

The Kappa agreement between Zenit RA CLIA and gold standard immunoprecipitation, as well as IB and IIFassays for the presence of anti-Scl-70(Topo I)(0.948) was excellent. The concordance between Zenit RA CLIA and gold standard immunoprecipitation for the presence of anti-U1snRNP (0.883), anti-Ro/SS-A (0.878), anti-Jo-1(histRNA-Synthetase) (0.791) and anti-Sm (0.786) was good, and excellent when the cut-off was raised to 14 U/ml (arbitrary units/ml). Between Zenit RA CLIA and gold standard immunoprecipitation for the presence of anti-La/SS-B, the Kappa agreement had a value of 0.689, but this improved to 0.775 when the cut-off was raised to14 U/ml. Precision was good based on the evaluation of replicate samples. Inter-assay coefficient variation was lower than 3.4 % (CV in %) in all the kits and <1.2 % (CV in  %) for intra-assay measurements.

Conclusion

Our findings show that Zenit RA CLIA was specific and sensitive to detect anti-U1snRNP, anti-Sm, anti-Ro/SS-A, anti-La/SS-B, anti-Jo-1(histRNA-Synthetase) and anti-Scl70(Topo I) autoantibodies. This simple, fast and precise method can be a suitable option to analyze these autoantibody specificities.
Literature
1.
go back to reference Tan EM, Chan EK, Sullivan KF, Rubin RL (1988) Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121–141PubMedCrossRef Tan EM, Chan EK, Sullivan KF, Rubin RL (1988) Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:121–141PubMedCrossRef
2.
go back to reference Gelpi C, Kanterewicz E, Gratacos J, Targoff IN et al (1996) Coexistence of two antisynthetases in a patient with the antisynthetase síndrome. Arthritis Rheum 39:692–697PubMedCrossRef Gelpi C, Kanterewicz E, Gratacos J, Targoff IN et al (1996) Coexistence of two antisynthetases in a patient with the antisynthetase síndrome. Arthritis Rheum 39:692–697PubMedCrossRef
3.
go back to reference Douvas A (1988) Does Scl-70 modulate collagen production in systemic sclerosis? Lancet 27:475–477CrossRef Douvas A (1988) Does Scl-70 modulate collagen production in systemic sclerosis? Lancet 27:475–477CrossRef
4.
go back to reference Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69:1420–1422PubMedCrossRef Meroni PL, Schur PH (2010) ANA screening: an old test with new recommendations. Ann Rheum Dis 69:1420–1422PubMedCrossRef
5.
go back to reference Lerner MR, Steitz JA (1979) Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 76:5495–5499PubMedPubMedCentralCrossRef Lerner MR, Steitz JA (1979) Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 76:5495–5499PubMedPubMedCentralCrossRef
6.
go back to reference Matter L, Schpfer K, Wilhelm JA et al (1982) Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies: a diagnostic evaluation. Arthritis Rheum 25:1278PubMedCrossRef Matter L, Schpfer K, Wilhelm JA et al (1982) Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies: a diagnostic evaluation. Arthritis Rheum 25:1278PubMedCrossRef
7.
go back to reference Hardin JA, Rahn DR, Shen C et al (1982) Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles. J Clin Invest 70:141–147PubMedPubMedCentralCrossRef Hardin JA, Rahn DR, Shen C et al (1982) Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles. J Clin Invest 70:141–147PubMedPubMedCentralCrossRef
8.
go back to reference Sharp GC, Irvin WS, Tan EM et al (1972) Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159PubMedCrossRef Sharp GC, Irvin WS, Tan EM et al (1972) Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159PubMedCrossRef
9.
go back to reference Juarez C, Vila JL, Gelpi C et al (1988) Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunosorbent assay. Arthritis Rheum 31:108–115PubMedCrossRef Juarez C, Vila JL, Gelpi C et al (1988) Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunosorbent assay. Arthritis Rheum 31:108–115PubMedCrossRef
10.
go back to reference Forman MS, Nakamura M, Mimori T, Gelpi C et al (1985) Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. Arthritis Rheum 28:1356–1361PubMedCrossRef Forman MS, Nakamura M, Mimori T, Gelpi C et al (1985) Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. Arthritis Rheum 28:1356–1361PubMedCrossRef
11.
go back to reference Gelpi C, Alguero A, Martinez MA et al (1990) Identification of protein components reactive with anti-PM/Scl autoantibodies. Clin Exp Immunol 81:59–64PubMedPubMedCentralCrossRef Gelpi C, Alguero A, Martinez MA et al (1990) Identification of protein components reactive with anti-PM/Scl autoantibodies. Clin Exp Immunol 81:59–64PubMedPubMedCentralCrossRef
12.
go back to reference Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24:145–149 Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24:145–149
13.
go back to reference Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29PubMedCrossRef Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29PubMedCrossRef
14.
go back to reference Greiner M, Sohr D, Göbel P (1995) A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 185:123–132PubMedCrossRef Greiner M, Sohr D, Göbel P (1995) A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 185:123–132PubMedCrossRef
15.
go back to reference Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
Metadata
Title
Efficiency of a solid-phase chemiluminescence immunoassay for detection of antinuclear and cytoplasmic autoantibodies compared with gold standard immunoprecipitation
Authors
Carmen Gelpí
Elena Pérez
Cristina Roldan
Publication date
01-09-2014
Publisher
Springer International Publishing
Published in
Autoimmunity Highlights / Issue 2/2014
Print ISSN: 2038-0305
Electronic ISSN: 2038-3274
DOI
https://doi.org/10.1007/s13317-014-0059-x
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.